Sun Jian David Acquires Shares of 111, Inc.
Sun Jian David purchased 413,168 shares of 111, Inc. on May 12, 2026.
Key Points
- Sun Jian David bought 413,168 shares of 111, Inc. on May 12, 2026, with shares trading at $4.57.
- 111, Inc. has a market cap of about $40.2 million and a forward P/E of 32.64, with shares ranging from $2.48 to $11.17 over 52 weeks.
- Renaissance Technologies added 300 shares of 111, Inc., while UBS Group AG reduced its stake by 203 shares.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Sun Jian David made a significant move by acquiring 413,168 shares of 111, Inc. (NasdaqGM: YI) on May 12, 2026. At the time, the shares were trading at $4.57. This purchase indicates confidence in the company's future prospects.
Other Institutional Activity in 111, Inc.
Several other institutional investors have adjusted their positions in 111, Inc. Renaissance Technologies LLC increased its holdings by 300 shares, bringing its total to 13,014 shares valued at approximately $84,851. On the other hand, UBS Group AG reduced its stake by 203 shares, ending with 100 shares worth about $652. Serenus Wealth Advisors, LLC slightly trimmed its position by 64 shares, resulting in 4,320 shares valued at $321,334.
111, Inc. Stock Up 30.2%
Shares of 111, Inc. (NasdaqGM: YI) traded around $4.57. The company has a market cap of approximately $40.2 million and a forward P/E ratio of 32.64. It has a beta of 0.609, indicating lower volatility compared to the market. The stock's 52-week range is between $2.48 and $11.17, with a 50-day moving average of $5.88 and a 200-day moving average of $5.40. The company's current ratio is 1.084, while its quick ratio is 0.366, and it has a debt-to-equity ratio of 150.925.
Recent Earnings
111, Inc. reported revenue of approximately $11.39 billion, although it experienced a revenue decline of 33.1%. The company's net margin stands at -0.753%, and its return on equity is -14.842%. The next earnings report is expected on March 19, 2026.
Insider Buying and Selling at 111, Inc.
In addition to Sun Jian David's purchase on May 12, 2026, there have been several insider sales. Sun Jian David sold 115,440 shares on June 10, 2026, at $0.22 per share. Similarly, Chen Yang Luke sold 44,000 shares on June 15, 2026, at $0.23 per share.
About 111, Inc.
111, Inc., headquartered in Shanghai, China, operates in the healthcare sector, focusing on medical distribution. It runs an integrated online and offline platform to serve pharmacies, pharmaceutical companies, and medical professionals in China. The company offers a range of services, including supply chain integration, product promotion, and online pharmacy operations. Founded in 2010, 111, Inc. employs over 1,000 people and is led by CEO Junling Liu.
Bottom Line
Sun Jian David's recent acquisition of shares in 111, Inc. highlights a noteworthy insider activity. Investors often track such transactions for potential insight into company prospects. This activity, however, is just one piece of the puzzle, and it's important to consider the broader financial context of 111, Inc., including its market performance and institutional investor actions.
Get 111, Inc. alerts
New 13F filings, insider trades, and analyst moves on $YI, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.